CTOs on the Move

MPI Research

www.mpiresearch.com

 
MPI Research, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. MPI Research, Inc. is based in Mattawan, MI. You can find more information on MPI Research, Inc. at www.mpiresearch.com
  • Number of Employees: 1K-5K
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Pathology, Inc.

Pathology Inc. is a 30 man pathology group headquartered in suburban Los Angeles, California offering multi-specialty pathology services for primary care and specialty physicians. The group also practices at 12 area hospitals.

IDLife Corporate

IDLife stands for “Individually Designed Life.” You really can have the best health you’ve ever experienced, the income you’ve always desired and the lifestyle you deserve. Healthy Simplified.

Acclivity Healthcare

Acclivity Healthcare is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Saint Mary`s Healthcare

St. Mary`s Healthcare offers a continuum of services designed to fulfill the total healthcare needs of the community, while being the lowest cost provider. In addition to our 143 bed hospital, a 160 bed nursing home and a 10 bed acute rehabilitation unit, St. Mary`s provides highly accessible healthcare through its seven offsite primary care centers and behavioral health service locations throughout two counties. We treat more than 290,000 outpatient visits a year. Founded by the Sisters of St. Joseph of Carondelet in 1903, and as a member of Ascension since 2002, St. Mary`s is dedicated to improving the health of the community with special attention to the poor and underserved. By addressing the spiritual, social, emotional and physical needs of our patients, we strive to provide an exceptional patient experience and a model community for our associates and medical staff.

Cellenkos Incorporated

Cellenkos is an early stage clinical biotechnology company that focuses on cord blood-derived T-regulatory cellular therapies for the treatment of autoimmune diseases and inflammatory conditions. Cellenkos is founded on the technologies arising from the laboratory investigations of Simrit Parmar, M.D. Cellenkos` lead product CK0801 delivers clinically meaningful doses of allogeneic cord blood T-regulatory cells to overcome immune dysfunction.